Select Medical Holdings Corporation Common Stock (SEM)

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Select Medical Holdings Corporation (NYSE: SEM) to a consortium led by Select Medical executives and directors. Under the terms of the proposed transaction, shareholders of Select Medical will receive $16.50 in cash for each share of Select Medical that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 

BALA CYNWYD, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Select Medical Holdings Corporation (“Select Medical” or the “Company”) (NYSE - SEM) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to a consortium of entities, including Robert A. Ortenzio, Executive Chairman, Co-Founder and Director of Select Medical for $16.50 per share in cash, representing an enterprise value of $3.9 billion.

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Select Medical Holdings Corporation (NYSE: SEM) to a consortium led by Select Medical executives and directors for $16.50 in cash per share.